Immix Biopharma, Inc.

Immix Biopharma, Inc.verified

IMMX

Price:

$2.175

Market Cap:

$59.83M

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in developing various tissue-specific therapeutics in oncology and inflammation in the United States and Australia. The company is developing IMX-110 that is in Phase 1b/2a clinical trials for the treatment of soft tissue sarcoma and solid tumors; IMX-111, a tissue-specific biologic for the treatment of colorectal cancers; and IMX-120, a tissue-specific biologic for the treatment of ulcerative colitis and severe Crohn's disease. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. The company was incorpor...[Read more]

Industry

Biotechnology

IPO Date

2021-12-16

Stock Exchange

NASDAQ

Ticker

IMMX

The ROE as of December 2024 (TTM) for Immix Biopharma, Inc. (IMMX) is -102.10%

According to Immix Biopharma, Inc.’s latest financial reports and current stock price. The company's current ROE is -102.10%. This represents a change of 274.73% compared to the average of -27.25% of the last 4 quarters.

Immix Biopharma, Inc. (IMMX) Historical ROE (quarterly & annually)

How has IMMX ROE performed in the past?

The mean historical ROE of Immix Biopharma, Inc. over the last ten years is -48.23%. The current -102.10% ROE has changed 111.68% with respect to the historical average. Over the past ten years (40 quarters), IMMX's ROE was at its highest in in the March 2021 quarter at 21.49%. The ROE was at its lowest in in the December 2021 quarter at -126.49%.

Quarterly (TTM)
Annual

Average

-48.23%

Median

-62.54%

Minimum

-135.54%

Maximum

26.68%

Immix Biopharma, Inc. (IMMX) ROE by Quarter and Year

Discovering the peaks and valleys of Immix Biopharma, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 50.36%

Maximum Annual ROE = 26.68%

Minimum Annual Increase = -658.59%

Minimum Annual ROE = -135.54%

Quarterly (TTM)
Annual
YearROEChange
2023-94.03%50.36%
2022-62.54%-53.86%
2021-135.54%-658.59%
202024.26%-9.05%

Immix Biopharma, Inc. (IMMX) Average ROE

How has IMMX ROE performed in the past?

The current ROE of Immix Biopharma, Inc. (IMMX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-97.37%

5-year avg

-48.23%

10-year avg

-48.23%

Immix Biopharma, Inc. (IMMX) ROE vs. Peers

How is IMMX’s ROE compared to its peers?

Immix Biopharma, Inc.’s ROE is greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Hepion Pharmaceuticals, Inc. (-505.74%), less than AVROBIO, Inc. (29.68%), less than eFFECTOR Therapeutics, Inc. (2.18%), less than CNS Pharmaceuticals, Inc. (695.91%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), greater than Sonnet BioTherapeutics Holdings, Inc. (-398.33%), less than Freeline Therapeutics Holdings plc (0%), greater than Enveric Biosciences, Inc. (-77.99%), greater than CohBar, Inc. (-201.01%), greater than Elevation Oncology, Inc. (-58.44%), greater than Ocean Biomedical, Inc. (-59.73%), less than null (75.64%),

Build a custom stock screener for Immix Biopharma, Inc. (IMMX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immix Biopharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immix Biopharma, Inc. (IMMX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immix Biopharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Immix Biopharma, Inc.'s ROE?

How is the ROE calculated for Immix Biopharma, Inc. (IMMX)?

What is the highest ROE for Immix Biopharma, Inc. (IMMX)?

What is the 3-year average ROE for Immix Biopharma, Inc. (IMMX)?

What is the 5-year average ROE for Immix Biopharma, Inc. (IMMX)?

How does the current ROE for Immix Biopharma, Inc. (IMMX) compare to its historical average?